Shenyang Xingqi Pharmaceutical News and Activities

Shenyang Xingqi Pharmaceutical is a company listed under the stock ticker 300573 (CN).

View the org chart displaying its 9 main executives

Most searched biographies at Shenyang Xingqi Pharmaceutical

• E Gao, General Manager and Director
• Jidong Liu, Chairman of the Board
• Xiaobin Dai, Independent Director

Create your alert
to follow the executive moves at Shenyang Xingqi Pharmaceutical.

Shenyang Xingqi Pharmaceutical has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Shenyang Xingqi Pharmaceutical

• 分享到QQ空间
• COMPANY NEWS-SINQI
• COMPANY EVENTS-SINQI

Social media about Shenyang Xingqi Pharmaceutical

• Shenyang Xingqi Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Shenyang Xingqi Pharmaceutical on LinkedIn, X (Twitter) & YouTube